MedPath

Primidone

PRIMIDONE TABLETS, USP

Approved
Approval ID

fe761fa9-d97c-4ef4-a816-96e237c8749c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 8, 2019

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Primidone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71610-191
Application NumberANDA084903
Product Classification
M
Marketing Category
C73584
G
Generic Name
Primidone
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 25, 2017
FDA Product Classification

INGREDIENTS (6)

PRIMIDONEActive
Quantity: 50 mg in 1 1
Code: 13AFD7670Q
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
METHYLCELLULOSE (400 MPA.S)Inactive
Code: O0GN6F9B2Y
Classification: IACT
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Primidone - FDA Drug Approval Details